MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 124 filers reported holding MERSANA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $73,670 | -80.5% | 22,392 | -65.3% | 0.00% | -85.0% |
| Q4 2022 | $378,632 | +25.8% | 64,613 | +44.9% | 0.02% | +66.7% |
| Q3 2022 | $301,000 | +11.9% | 44,598 | -33.9% | 0.01% | 0.0% |
| Q1 2022 | $269,000 | -40.6% | 67,500 | -7.4% | 0.01% | -57.1% |
| Q4 2021 | $453,000 | +10.8% | 72,900 | +187.8% | 0.03% | -26.3% |
| Q1 2021 | $409,000 | – | 25,332 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |